BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23893313)

  • 1. Effect of HLA mismatch on acute graft-versus-host disease.
    Kanda J
    Int J Hematol; 2013 Sep; 98(3):300-8. PubMed ID: 23893313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
    Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
    Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.
    Ciurea SO; Saliba RM; Rondon G; Patah PA; Aung F; Cano P; Andersson BS; Kebriaei P; Popat U; Fernandez-Vina M; Champlin RE; de Lima M
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):923-9. PubMed ID: 20969970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
    Martin PJ; Levine DM; Storer BE; Warren EH; Zheng X; Nelson SC; Smith AG; Mortensen BK; Hansen JA
    Blood; 2017 Feb; 129(6):791-798. PubMed ID: 27872059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
    Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.
    Petersdorf EW; Carrington M; O'hUigin C; Bengtsson M; De Santis D; Dubois V; Gooley T; Horowitz M; Hsu K; Madrigal JA; Maiers MJ; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P;
    Lancet Haematol; 2020 Jan; 7(1):e50-e60. PubMed ID: 31669248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
    Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
    Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
    Lazaryan A; Wang T; Spellman SR; Wang HL; Pidala J; Nishihori T; Askar M; Olsson R; Oudshoorn M; Abdel-Azim H; Yong A; Gandhi M; Dandoy C; Savani B; Hale G; Page K; Bitan M; Reshef R; Drobyski W; Marsh SG; Schultz K; Müller CR; Fernandez-Viña MA; Verneris MR; Horowitz MM; Arora M; Weisdorf DJ; Lee SJ
    Haematologica; 2016 Oct; 101(10):1267-1274. PubMed ID: 27247320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which factors influence the development of GVHD in HLA-matched or mismatched transplants?
    Petersdorf EW
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):333-335. PubMed ID: 29156205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
    Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
    Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study.
    Kanda J; Saji H; Fukuda T; Kobayashi T; Miyamura K; Eto T; Kurokawa M; Kanamori H; Mori T; Hidaka M; Iwato K; Yoshida T; Sakamaki H; Tanaka J; Kawa K; Morishima Y; Suzuki R; Atsuta Y; Kanda Y
    Blood; 2012 Mar; 119(10):2409-16. PubMed ID: 22042692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients.
    Nishida T; Murayama T; Hirai H; Okamoto S; Sao H; Hara M; Kanamori H; Atsuta Y; Matsuo K; Morishima Y; Kodera Y
    Int J Hematol; 2009 Jan; 89(1):98-105. PubMed ID: 19052693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.
    Yabe T; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Morishima S; Satake M; Takanashi M; Nakajima K; Morishima Y;
    Leukemia; 2018 Jan; 32(1):168-175. PubMed ID: 28652579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation.
    Rockstroh A; Al-Ali HK; Lange T; Pönisch W; Krahl R; Cross M; Behre G; Niederwieser D; Pfrepper C
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2193-203. PubMed ID: 26129640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.
    Petersdorf EW; Bengtsson M; De Santis D; Dubois V; Fleischhauer K; Gooley T; Horowitz M; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P; Carrington M; ;
    J Clin Oncol; 2020 Aug; 38(24):2712-2718. PubMed ID: 32479188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.